<DOC>
	<DOCNO>NCT01242176</DOCNO>
	<brief_summary>The objective study investigate relative bioavailability final tablet formulation ( FF ) BI 10773 comparison tablet formulation 2 ( TF2 ) .</brief_summary>
	<brief_title>Relative Bioavailability Empagliflozin ( BI 10773 ) ( Final Formulation ) Compared Empagliflozin ( BI 10773 XX ) ( Trial Formulation 2 ) Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : Healthy male female subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>